ASCENTAGE PHARMA GROUP(AAPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AAPG ASCENTAGE PHARMA GROUP

Trading 04-16 11:41:51 EDT

27.16

+0.04

+0.15%

High27.16	Low27.15	Vol329.00
Open27.15	D1 Closing27.12	Amplitude0.04%
Mkt Cap2.53B	Tradable Cap1.94B	Total Shares93.33M
T/O8.93K	T/O Rate0.00%	Tradable Shares71.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AAPG","market":"US","secType":"STK","nameCN":"ASCENTAGE PHARMA GROUP","latestPrice":27.16,"timestamp":1776353622039,"preClose":27.12,"halted":0,"volume":329,"delay":0,"changeRate":0.0014749262536872842,"floatShares":71582800,"shares":93330405,"eps":-1.995679,"marketStatus":"Trading","change":0.04,"latestTime":"04-16 11:41:51 EDT","open":27.15,"high":27.16,"low":27.15,"amount":8926.281924,"amplitude":0.000369,"askPrice":27.16,"askSize":1110,"bidPrice":26.49,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-1.995679,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1776369600000},"marketStatusCode":2,"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":27.12,"preHourTrading":{"tag":"盘前","latestPrice":27.16,"preClose":27.12,"latestTime":"04:49 EDT","volume":56,"amount":1520.76008,"timestamp":1776329390780,"change":0.04,"changeRate":0.001475,"amplitude":0.000369},"postHourTrading":{"tag":"盘后","latestPrice":27.18,"preClose":27.09,"latestTime":"18:37 EDT","volume":406,"amount":11034.72,"timestamp":1776292632100,"change":0.09,"changeRate":0.003322,"amplitude":0.003322},"volumeRatio":0.687055},"requestUrl":"/m/hq/s/AAPG/wiki","defaultTab":"wiki","newsList":[{"id":"2627243025","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zimmer Biomet Holdings (ZBH) and Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627243025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627243025?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:50","pubTimestamp":1776081011,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS), Zimmer Biomet Holdings (ZBH) and Ascen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-zimmer-biomet-holdings-zbh-and-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-zimmer-biomet-holdings-zbh-and-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","LU0648001328.SGD","BK4504","LU0211327993.USD","LU0980610538.SGD","XBI","BK4082","LU0128526141.USD","LU1201861249.SGD","LU1267930573.SGD","BK4566","IE00B7SZLL34.SGD","BK4137","HMYY","BK4581","LABU","LU0792757196.USD","HIMZ","LU0006061336.USD","LU0029864427.USD","IE0002270589.USD","LU0889566641.SGD","BK4139","BK4196","HIMS","LU1267930490.SGD","LU1267930813.SGD","LU0130102774.USD","ZBH","IE00B19Z3B42.SGD","LU0477156953.USD","LU0708994859.HKD","HIMY","LU0211328371.USD","LU0310799852.SGD","LU0029874061.USD","BK4588","HIYY","LU0310800379.SGD","BK4585","LU0130517989.USD","AAPG","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626194124","title":"Piper Sandler Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626194124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626194124?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:16","pubTimestamp":1775819808,"startTime":"0","endTime":"0","summary":"In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on Ascentage Pharma Group International Unsponsored ADR, with a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622687590","title":"Ascentage Pharma Builds Momentum With 2 'Potential Blockbuster' Drugs, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2622687590","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622687590?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:26","pubTimestamp":1774625210,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group (AAPG) is entering 2026 with growing commercial momentum in China and a pipeline nearing major global readouts, including two \"potential blockbuster\" drugs, Oppenheimer said Fri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AAPG","OPY","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116979923","title":"Stock Track | Ascentage Pharma Group Soars 8.56% Intraday on Positive Analyst Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1116979923","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116979923?lang=en_us&edition=fundamental","pubTime":"2026-03-27 22:33","pubTimestamp":1774621984,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group's stock surged 8.56% during intraday trading on Friday, driven by positive analyst sentiment from two major financial firms.Truist Financial analyst Gregory Renza maintained a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823324","title":"BTIG Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823324","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823324?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:57","pubTimestamp":1774609065,"startTime":"0","endTime":"0","summary":"BTIG analyst Jeet Mukherjee reiterated a Buy rating on Ascentage Pharma Group International Unsponsored ADR yesterday and set a price target of $48...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622850096","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2622850096","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622850096?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:56","pubTimestamp":1774529810,"startTime":"0","endTime":"0","summary":"Health care stocks were leaning lower premarket Thursday, with the State Street Health Care Select Sector SPDR ETF  down 0.2% and the iShares Biotechnology ETF  declining by 0.7%.Ascentage Pharma Group  shares were down more than 2% after the company reported a wider 2025 loss as revenue declined during the period.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","XLV","LU0061475181.USD","BK4588","BK4135","BK4581","IE00B3QW5Z07.USD","BK4139","AAPG","IE00BGHQF748.EUR","IBB","IE0034235188.USD","LU1894683348.USD","LU1894683264.USD","IE00B64PRP62.GBP","LU1883839398.USD","XBI","BK4585","BK4550","STT","FDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622834405","title":"Ascentage Pharma's 2025 Loss Widens, Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2622834405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622834405?lang=en_us&edition=fundamental","pubTime":"2026-03-26 15:47","pubTimestamp":1774511272,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group  reported a 2025 loss late Wednesday of 3.49 Chinese renminbi  per diluted share, widening from a loss of 1.34 renminbi a year earlier.Two analysts polled by FactSet expected 2.22 renminbi.Revenue for the year ended Dec. 31 was 574.1 million renminbi, compared with 980.7 million renminbi a year earlier.Four analysts polled by FactSet expected 525.3 million renminbi.As of Dec. 31, 2025, cash and bank balances were $353.2 million, compared with $172.8 million a year earlier.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189397132","title":"ASCENTAGE-B Reports Strong Growth Driven by Dual Commercial Engines","url":"https://stock-news.laohu8.com/highlight/detail?id=1189397132","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189397132?lang=en_us&edition=fundamental","pubTime":"2026-03-26 07:32","pubTimestamp":1774481547,"startTime":"0","endTime":"0","summary":"On March 26, leading innovative drug company ASCENTAGE PHARMA GROUP released its full-year 2025 results. During the reporting period, the company achieved total revenue of 574 million Chinese yuan,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1574","AAPG","BK1161","06855"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622888069","title":"Press Release: Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622888069","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622888069?lang=en_us&edition=fundamental","pubTime":"2026-03-26 07:00","pubTimestamp":1774479600,"startTime":"0","endTime":"0","summary":"-- Product sales and commercial rights revenues in 2025 increased 90%. -- Sales of Olverembatinib increased 81% year-over-year to US$62.2 million. -- Sales of Lisaftoclax since launch during last five months of 2025 were. Dr. Dajun Yang, Chairman and Chief Executive Officer of Ascentage Pharma, said, \"2025 was a year of significant execution in advancing our mission to deliver innovative therapies to patients worldwide. We advanced our commercialization strategy as Olverembatinib gained significant traction after receiving NRDL coverage expansion, which has markedly enhanced affordability and accessibility for patients in China. We launched Lisaftoclax in China in late July 2025 shortly after receiving regulatory approval and are gaining market adoption as we actively pursue the inclusion of Lisaftoclax in China's NRDL.\". Olverembatinib  is a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI approved in China for treatment of patients with chronic myeloid leukemia ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","CDE","BK4585","LU1223082196.USD","BK6008","BK1161","BK1574","LABU","LU1223083913.SGD","EMA","PK","BK6514","BK4017","5BI.SI","BK4181","06855","LU1223082519.USD","BK4588","AAPG","BK4081","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134901961","title":"ASCENTAGE-B to Present Four Preclinical Studies at 2026 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1134901961","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134901961?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:20","pubTimestamp":1773793217,"startTime":"0","endTime":"0","summary":"ASCENTAGE-B (06855) announced that four of its preclinical research advancements have been selected for presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AAPG","06855","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620640432","title":"Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620640432","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620640432?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:00","pubTimestamp":1773792000,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, March  17, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/18/3257844/0/en/Ascentage-Pharma-to-Present-Data-From-Four-Preclinical-Studies-In-Its-Innovative-Pipeline-at-American-Association-of-Cancer-Research-AACR-Annual-Meeting-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","EC","BK4107","BK4139","AAPG","BK4117","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618975797","title":"Ascentage Pharma initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2618975797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618975797?lang=en_us&edition=fundamental","pubTime":"2026-03-12 04:29","pubTimestamp":1773260978,"startTime":"0","endTime":"0","summary":"BTIG analyst Jeet Mukherjee initiated coverage of Ascentage Pharma (AAPG) with a Buy rating and $48 price target The firm says the China-built biop...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618942948","title":"Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942948","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942948?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:00","pubTimestamp":1773230400,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, March  11, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as “Ascentage Pharma,” the “Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3253683/0/en/Ascentage-Pharma-to-Report-Full-Year-2025-Unaudited-Financial-Results-and-Provide-Business-Updates-on-March-25-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613978243","title":"Ascentage Pharma to Participate in Three Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2613978243","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613978243?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:00","pubTimestamp":1771851600,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, Feb.  23, 2026  (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”),a global, commercial stage, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/23/3242582/0/en/Ascentage-Pharma-to-Participate-in-Three-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610729653","title":"Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2610729653","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610729653?lang=en_us&edition=fundamental","pubTime":"2026-02-09 21:00","pubTimestamp":1770642000,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, Feb.  09, 2026  (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company, a global, commercial stage, i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/09/3234476/0/en/Ascentage-Pharma-to-Participate-in-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","LABU","BK4211","BK4585","BK4139","BK4588","SMMF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609569413","title":"Ascentage Pharma Says Bruton's Tyrosine Kinase-Targeted Protein Degrader Application Gets China Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2609569413","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609569413?lang=en_us&edition=fundamental","pubTime":"2026-02-06 17:52","pubTimestamp":1770371561,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International (AAPG) said late Thursday that China Center for Drug Evaluation cleared the company's investigational new drug application for Bruton's tyrosine kinase-targeted pr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609533250","title":"Ascentage Pharma announces IND clearance by the China CDE for APG-3288","url":"https://stock-news.laohu8.com/highlight/detail?id=2609533250","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609533250?lang=en_us&edition=fundamental","pubTime":"2026-02-06 07:35","pubTimestamp":1770334517,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (AAPG) “announced that its novel next-generation Bruton’s tyrosine kinase-targeted protein degrader, APG-3288, has received invest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-announces-ind-clearance-by-the-china-cde-for-apg-3288-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-announces-ind-clearance-by-the-china-cde-for-apg-3288-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","CDE","BK4017","APG","LU1223082519.USD","LU1923622291.USD","BK4129","AAPG","BK4139","LU2125909759.SGD","LU2125909916.SGD","LU1223082196.USD","LU1223083913.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609533068","title":"Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288","url":"https://stock-news.laohu8.com/highlight/detail?id=2609533068","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609533068?lang=en_us&edition=fundamental","pubTime":"2026-02-06 07:30","pubTimestamp":1770334200,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, Feb.  05, 2026  (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/05/3233530/0/en/Ascentage-Pharma-Announces-IND-Clearance-by-the-China-CDE-for-BTK-Degrader-APG-3288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0511384066.AUD","LU2023251221.USD","LU2111349929.HKD","CDE","LU0472753341.HKD","LU2106854487.HKD","LU2125909916.SGD","LU0347712357.USD","BK4585","LU2413666699.HKD","BK4533","AAPG","LU2271345857.HKD","LU2125909759.SGD","LU1917777945.USD","BK4588","BCR","LU1923622291.USD","LU0057025933.USD","LU1223083913.SGD","LU1430594728.SGD","LU1712237335.SGD","LU2089283258.USD","BK4181","LU2298064838.USD","LU1939255532.USD","APG","PK","BK4139","LU0124676726.USD","LU2240825500.USD","LU2023250504.SGD","LU2413666426.HKD","LU1223082196.USD","LU0289739343.SGD","LU2463526074.USD","LU0158827948.USD","IND","LU1989772923.USD","LU2041044095.USD","LU2362541513.USD","LU1892829315.USD","LU2362540622.SGD","LU2238339852.HKD","LU1989772840.SGD","LU1923621640.USD","LU2308191902.HKD","LU2089284900.SGD","WM","LU0289960550.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128142501","title":"ASCENTAGE-B Stock Surges Over 3% in Intraday Trading as BTK Degrader Class 1 New Drug APG-3288 Tablets Gain Clinical Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1128142501","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128142501?lang=en_us&edition=fundamental","pubTime":"2026-02-04 11:12","pubTimestamp":1770174738,"startTime":"0","endTime":"0","summary":"Shares of ASCENTAGE PHARMA GROUP - B (06855) climbed more than 3% during the trading session. At the time of writing, the stock was up 1.38%, trading at HK$45.88, with a turnover of HK$36.975...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4139","LU2125909759.SGD","06855","APG","LU2125909916.SGD","BK1574","AAPG","LU1923622291.USD","BK4129"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603216076","title":"Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2603216076","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603216076?lang=en_us&edition=fundamental","pubTime":"2026-01-15 09:25","pubTimestamp":1768440300,"startTime":"0","endTime":"0","summary":"Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation BTK protein degrader APG-3288 receives IND clearance f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/15/3219202/0/en/Ascentage-Pharma-Outlined-its-Global-Innovation-Strategy-During-Presentation-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0158827948.USD","AAPG","LU0314104364.USD","LU1363072403.SGD","LU1720051108.HKD","XBI","LU0912757837.SGD","LU1668664300.SGD","LABU","LU1074936037.SGD","LU2089284900.SGD","BK4585","LU1989772923.USD","LU2089283258.USD","IE00BKVL7J92.USD","LU1732800096.USD","LU1791710400.SGD","LU2111349929.HKD","BK4588","BK4534","LU2133065610.SGD","LU0882574139.USD","LU0029874061.USD","LU0795875086.SGD","LU0225283273.USD","LU2347655156.SGD","LU1732799900.SGD","BK4127","LU0795875169.SGD","BK4581","LU1989772840.SGD","IE00BZ1G4Q59.USD","LU1244550577.SGD","HCSG","LU0267386448.USD","LU1791710582.SGD","LU1162221912.USD","LU1244550494.USD","BK4139","BK4137","XLV","LU1548497426.USD","LU0106261372.USD","LU0234570918.USD","LU0158827781.USD","LU2028103732.USD","LU2271345857.HKD","IND","LU0006306889.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascentage.com","stockEarnings":[{"period":"1week","weight":0.02},{"period":"1month","weight":0.1053},{"period":"3month","weight":-0.0077},{"period":"6month","weight":-0.2356},{"period":"1year","weight":0.3928},{"period":"ytd","weight":0.0324}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"ASCENTAGE PHARMA GROUP","nameEN":"ASCENTAGE PHARMA GROUP","securityTypeName":"DR","adrRate":"1:4"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ASCENTAGE PHARMA GROUP(AAPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ASCENTAGE PHARMA GROUP(AAPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ASCENTAGE PHARMA GROUP,AAPG,ASCENTAGE PHARMA GROUP股票,ASCENTAGE PHARMA GROUP股票老虎,ASCENTAGE PHARMA GROUP股票老虎国际,ASCENTAGE PHARMA GROUP行情,ASCENTAGE PHARMA GROUP股票行情,ASCENTAGE PHARMA GROUP股价,ASCENTAGE PHARMA GROUP股市,ASCENTAGE PHARMA GROUP股票价格,ASCENTAGE PHARMA GROUP股票交易,ASCENTAGE PHARMA GROUP股票购买,ASCENTAGE PHARMA GROUP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ASCENTAGE PHARMA GROUP(AAPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ASCENTAGE PHARMA GROUP(AAPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction